Is Tectonic Therapeutic, Inc. (TECX) a Buy, Sell, or Hold?
NASDAQ : TECX
Tectonic Therapeutic, Inc.
$32.5 USD
-$2.31 (-6.64%)
- Volume
- 240.85K
- Average Volume
- 206.44K
- Market Capitalization
- $613.25M
- P/E Ratio
- -7.29
- Dividend Yield
- 0.00%
- Price Target
- $78.00
- Year High
- $39.53
- Year Low
- $14.39
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.51
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
36
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
20
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$59687
TECX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
TECX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| McNamara Peter | officer: Chief Scientific Officer | 2026-06-30 | M-Exempt | 14.71 | 2026-07-01 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-06-30 | S-Sale | 35 | 2026-07-01 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-06-30 | M-Exempt | 14.71 | 2026-07-01 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2026-06-20 | F-InKind | 30.34 | 2026-06-23 |
| Lochner Daniel | officer: Chief Financial Officer | 2026-06-11 | A-Award | 16.8 | 2026-06-12 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2026-06-09 | A-Award | 28.56 | 2026-06-10 |
| Tipirneni Praveen P. | director | 2026-06-09 | A-Award | 28.56 | 2026-06-10 |
| Donenberg Phillip B. | director | 2026-06-09 | A-Award | 28.56 | 2026-06-10 |
| Vitorovic Stefan | director | 2026-06-09 | A-Award | 28.56 | 2026-06-10 |
| Chutter Jessica Caroline | director | 2026-06-08 | A-Award | 29.1 | 2026-06-10 |
| Chutter Jessica Caroline | 2026-06-08 | 0 | 2026-06-10 | ||
| Ruddy Marcella K. | officer: Chief Medical Officer | 2026-05-04 | S-Sale | 30 | 2026-05-06 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2026-04-01 | S-Sale | 31.05 | 2026-04-03 |
| Nader Francois | director | 2026-04-01 | A-Award | 30.78 | 2026-04-03 |
| Nader Francois | 2026-04-01 | 0 | 2026-04-03 | ||
| Ruddy Marcella K. | officer: Chief Medical Officer | 2026-03-06 | S-Sale | 30 | 2026-03-09 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-06 | M-Exempt | 14.71 | 2026-03-09 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-06 | M-Exempt | 2.38 | 2026-03-09 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-06 | S-Sale | 30 | 2026-03-09 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-06 | S-Sale | 35 | 2026-03-09 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-06 | M-Exempt | 2.38 | 2026-03-09 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-06 | M-Exempt | 14.71 | 2026-03-09 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2026-03-04 | A-Award | 0 | 2026-03-05 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2026-03-04 | A-Award | 27.41 | 2026-03-05 |
| Schwabish Marc | officer: Chief Business Officer | 2026-03-04 | A-Award | 0 | 2026-03-05 |
| Schwabish Marc | officer: Chief Business Officer | 2026-03-04 | A-Award | 27.41 | 2026-03-05 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-04 | A-Award | 0 | 2026-03-05 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-04 | S-Sale | 25 | 2026-03-05 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-03 | S-Sale | 22.06 | 2026-03-05 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-03-04 | A-Award | 27.41 | 2026-03-05 |
| Lochner Daniel | officer: Chief Financial Officer | 2026-03-04 | A-Award | 0 | 2026-03-05 |
| Lochner Daniel | officer: Chief Financial Officer | 2026-03-04 | A-Award | 27.41 | 2026-03-05 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2026-03-04 | A-Award | 0 | 2026-03-05 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2026-03-04 | A-Award | 27.41 | 2026-03-05 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2026-02-11 | P-Purchase | 21.1 | 2026-03-05 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2026-02-11 | P-Purchase | 21.1 | 2026-02-12 |
| Schwabish Marc | officer: Chief Business Officer | 2026-02-10 | M-Exempt | 2.38 | 2026-02-12 |
| Schwabish Marc | officer: Chief Business Officer | 2026-02-10 | M-Exempt | 2.38 | 2026-02-12 |
| Lochner Daniel | officer: Chief Financial Officer | 2026-02-10 | P-Purchase | 21.61 | 2026-02-11 |
| Schwabish Marc | officer: Chief Business Officer | 2026-02-04 | F-InKind | 23.22 | 2026-02-10 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2026-02-04 | F-InKind | 23.22 | 2026-02-10 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2026-02-04 | F-InKind | 23.22 | 2026-02-10 |
| McNamara Peter | officer: Chief Scientific Officer | 2026-02-04 | F-InKind | 23.22 | 2026-02-10 |
| Lochner Daniel | officer: Chief Financial Officer | 2026-02-04 | F-InKind | 23.22 | 2026-02-10 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2025-12-31 | M-Exempt | 2.38 | 2026-01-05 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2025-12-31 | M-Exempt | 2.38 | 2026-01-05 |
| McNamara Peter | officer: Chief Scientific Officer | 2025-12-22 | M-Exempt | 2.98 | 2025-12-29 |
| McNamara Peter | officer: Chief Scientific Officer | 2025-12-22 | M-Exempt | 2.98 | 2025-12-29 |
| Schwabish Marc | officer: Chief Business Officer | 2025-09-25 | A-Award | 0 | 2025-09-29 |
| Schwabish Marc | officer: Chief Business Officer | 2025-09-25 | A-Award | 14.71 | 2025-09-29 |
| McNamara Peter | officer: Chief Scientific Officer | 2025-09-25 | A-Award | 0 | 2025-09-29 |
| McNamara Peter | officer: Chief Scientific Officer | 2025-09-25 | A-Award | 14.71 | 2025-09-29 |
| Lochner Daniel | officer: Chief Financial Officer | 2025-09-25 | A-Award | 0 | 2025-09-29 |
| Lochner Daniel | officer: Chief Financial Officer | 2025-09-25 | A-Award | 14.71 | 2025-09-29 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2025-09-25 | A-Award | 0 | 2025-09-29 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2025-09-25 | A-Award | 14.71 | 2025-09-29 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2025-09-25 | A-Award | 0 | 2025-09-29 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2025-09-25 | A-Award | 14.71 | 2025-09-29 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2025-06-20 | F-InKind | 19.81 | 2025-06-24 |
| Donenberg Phillip B. | director | 2025-06-09 | A-Award | 24.48 | 2025-06-11 |
| Vitorovic Stefan | director | 2025-06-09 | A-Award | 24.48 | 2025-06-11 |
| MCGUIRE TERRANCE | director | 2025-06-09 | A-Award | 24.48 | 2025-06-11 |
| Tipirneni Praveen P. | director | 2025-06-09 | A-Award | 24.48 | 2025-06-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-06-09 | A-Award | 24.48 | 2025-06-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-11 | P-Purchase | 16.31 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-10 | P-Purchase | 16.73 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-09 | P-Purchase | 15.23 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-09 | P-Purchase | 14.62 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-11 | P-Purchase | 16.31 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-10 | P-Purchase | 16.73 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-09 | P-Purchase | 15.23 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-09 | P-Purchase | 14.62 | 2025-04-11 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-07 | P-Purchase | 17.1 | 2025-04-09 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-04-07 | P-Purchase | 17.1 | 2025-04-09 |
| MCGUIRE TERRANCE | director | 2025-04-07 | S-Sale | 17.1 | 2025-04-07 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-02-05 | P-Purchase | 54.14 | 2025-02-07 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2025-02-05 | P-Purchase | 50 | 2025-02-07 |
| Lochner Daniel | officer: Chief Financial Officer | 2025-02-05 | P-Purchase | 54.14 | 2025-02-07 |
| McNamara Peter | officer: Chief Scientific Officer | 2025-02-04 | A-Award | 0 | 2025-02-06 |
| McNamara Peter | officer: Chief Scientific Officer | 2025-02-04 | A-Award | 48.01 | 2025-02-06 |
| Schwabish Marc | officer: Chief Business Officer | 2025-02-04 | A-Award | 48.01 | 2025-02-06 |
| Schwabish Marc | officer: Chief Business Officer | 2025-02-04 | A-Award | 0 | 2025-02-06 |
| Lochner Daniel | officer: Chief Financial Officer | 2025-02-04 | A-Award | 48.01 | 2025-02-06 |
| Lochner Daniel | officer: Chief Financial Officer | 2025-02-04 | A-Award | 0 | 2025-02-06 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2025-02-04 | A-Award | 0 | 2025-02-06 |
| Ruddy Marcella K. | officer: Chief Medical Officer | 2025-02-04 | A-Award | 48.01 | 2025-02-06 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2025-02-04 | A-Award | 0 | 2025-02-06 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2025-02-04 | A-Award | 48.01 | 2025-02-06 |
| Schwabish Marc | officer: Chief Business Officer | 2025-01-28 | M-Exempt | 2.38 | 2025-01-29 |
| Schwabish Marc | officer: Chief Business Officer | 2025-01-28 | M-Exempt | 2.38 | 2025-01-29 |
| Schwabish Marc | officer: Chief Business Officer | 2024-12-09 | M-Exempt | 2.38 | 2024-12-11 |
| Schwabish Marc | officer: Chief Business Officer | 2024-12-09 | M-Exempt | 2.38 | 2024-12-11 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2024-12-04 | A-Award | 0 | 2024-12-06 |
| REICIN ALISE | director, officer: Chief Executive Officer | 2024-12-04 | A-Award | 51.28 | 2024-12-06 |
| McNamara Peter | officer: Chief Scientific Officer | 2024-12-03 | M-Exempt | 2.38 | 2024-12-05 |
| McNamara Peter | officer: Chief Scientific Officer | 2024-12-03 | M-Exempt | 2.38 | 2024-12-05 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2024-10-22 | P-Purchase | 33.59 | 2024-10-24 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2024-09-26 | P-Purchase | 30.87 | 2024-09-26 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2024-09-26 | P-Purchase | 30.1 | 2024-09-26 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | 2024-09-26 | P-Purchase | 29.13 | 2024-09-26 |